3,4-Methylenedioxy-N-methylphentermine
3,4-Methylenedioxy-N-methylphentermine (MDMP or 3,4-methylenedioxy-α,α,N-trimethylphenethylamine) is a lesser-known psychedelic drug. MDMP was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 110 mg, and the duration is listed as approximately 6 hours.[1] MDMP produces few to no effects, and is slightly similar to MDMA. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMP.
Names | |
---|---|
IUPAC name
1-(1,3-Benzodioxol-5-yl)-N,2-dimethylpropan-2-amine | |
Identifiers | |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider | |
PubChem CID |
|
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C12H17NO2 | |
Molar mass | 207.273 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Legality
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]
gollark: Oh. Oh, right.
gollark: Anyway, it seems that due to a minor issue of some sort in my code somewhere, this always produces zero. What joy.
gollark: Belgium doesn't *actually* exist.
gollark: Wow, I sure "fixed" my code.
gollark: Oh bee oh apions.
See also
- Phenethylamine
- Psychedelics, dissociatives and deliriants
References
- MDMP entry in PiHKAL
- "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.